TrademarkDir
Serial #88317260
LIVE

Serial Number

88317260

Owner

Inmedix, Inc.

Attorney

Jonathan A. Menkes

Filing Date

Feb 26, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #88317260 Trademark

Serial Number: 88317260 • Registration: 7218983

Serial #88317260 is a trademark filed by Inmedix, Inc. on February 26, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Inmedix, Inc. (6 trademarks)

Normandy Park, WA 98148

Entity Type: 03

Trademark Details

Filing Date

February 26, 2019

Registration Date

November 14, 2023

Published for Opposition

July 21, 2020

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 14, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 10, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 19, 2023 SUPC
USE AMENDMENT FILED
Sep 15, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 15, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 24, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 23, 2023 EX5G
SOU EXTENSION 5 FILED
Mar 15, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2022 EXRA
SOU EXTENSION 4 GRANTED
Sep 14, 2022 EX4G
SOU EXTENSION 4 FILED
Sep 14, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 14, 2022 EEXT
CORRECTED NOA E-MAILED
May 21, 2022 NOAC
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2022 EXRA
SOU EXTENSION 3 GRANTED
May 19, 2022 EX3G
DIVISIONAL PROCESSING COMPLETE
May 19, 2022 DPCC
RESPONSE TO ITU OFFICE ACTION ENTERED
Mar 29, 2022 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 29, 2022 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Mar 25, 2022 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 25, 2022 AITU
SOU EXTENSION 3 FILED
Mar 15, 2022 EXT3
DIVISIONAL REQUEST RECEIVED
Mar 15, 2022 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Mar 15, 2022 ERTD
SOU TEAS EXTENSION RECEIVED
Mar 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2021 EXRA
SOU EXTENSION 2 GRANTED
Sep 15, 2021 EX2G
SOU EXTENSION 2 FILED
Sep 15, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 15, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 12, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2020 CRFA
ASSIGNED TO LIE
Jun 5, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2020 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 28, 2020 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 28, 2020 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 28, 2020 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 28, 2020 CPEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 27, 2019 GNFN
FINAL REFUSAL E-MAILED
Nov 27, 2019 GNFR
FINAL REFUSAL WRITTEN
Nov 27, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2019 CNRT
ASSIGNED TO EXAMINER
May 7, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 21, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2019 NWOS
NEW APPLICATION ENTERED
Mar 1, 2019 NWAP

Related Trademarks

More from this Owner

CLOUDHRV

CLOUDHRV

CLOUDHRV

CLOUDHRV

CLOUDHRV

CLOUDHRV

CLOUDHRV

CLOUDHRV

INMEDIX

INMEDIX

INMEDIX INNOVATIVE MEDICAL DISCOVERY logo

INMEDIX INNOVATIVE MEDICAL DISCOVERY